Ligand Pharmaceuticals Incorporated (LGND) Insider Trading
- $5,339,328.39
- $219,280,051.93
- March 4, 2025
- John L Higgins
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Sept. 23, 2013 | major shareholder | 359,023 | $44.50 | Sell | $15,976,523.50 | |
| Sept. 12, 2013 | Director | 160,000 | $46.78 | Sell | $7,484,800.00 | |
| Aug. 30, 2013 | VP | 28,323 | $47.54 | Sell | $1,346,475.42 | |
| Aug. 16, 2013 | CEO | 10,000 | $42.85 | Sell | $428,500.00 | |
| Aug. 16, 2013 | VP | 14,583 | $42.63 | Sell | $621,673.29 | |
| Aug. 16, 2013 | CFO | 7,500 | $42.75 | Sell | $320,625.00 | |
| June 28, 2013 | COO | 1,059 | $17.36 | Buy | $18,384.24 | |
| May 10, 2013 | VP | 4,000 | $26.66 | Sell | $106,640.00 | |
| Jan. 23, 2013 | Major Shareholder | 39,600 | $19.78 | Buy | $783,288.00 | |
| Dec. 14, 2012 | Major Shareholder | 5,386 | $18.63 | Buy | $100,341.18 | |
| Dec. 6, 2012 | Major Shareholder | 50,100 | $17.94 | Buy | $898,794.00 | |
| Dec. 5, 2012 | CEO | 2,000 | $18.03 | Buy | $36,060.00 | |
| Oct. 31, 2012 | Major Shareholder | 16,591 | $15.19 | Buy | $252,017.29 | |
| Aug. 29, 2012 | Director | 2,743 | $16.36 | Buy | $44,875.48 |
Insiders are both buying and selling Ligand Pharmaceuticals Incorporated stock.
The insider traders at Ligand Pharmaceuticals Incorporated are: Matthew W Foehr, John L Higgins, Jason Aryeh, John W Kozarich, Charles S Berkman, Matthew E Korenberg, Octavio Espinoza, Todd C Davis, Andrew Reardon, Bvf Partners L P/Il, John L Lamattina, Stephen L Sabba, David M Knott, Bvf Partners P/Il, Melanie J Herman, John Sharp, Matthew Foehr, David Knott, Nishan M Desilva, Charles Berkman, Sunil Patel, John Lamattina, Todd Davis, John W. Kozarich, Melanie J. Herman, and John Higgins
The most active insider trader at Ligand Pharmaceuticals Incorporated is Matthew W Foehr with 27 trades.
Bvf Partners P/Il has sold the most Ligand Pharmaceuticals Incorporated stock with a total value of $58,156,493.18.
Bvf Partners L P/Il has bought the most Ligand Pharmaceuticals Incorporated stock with a total value of $2,817,728.47.
The most recent insider trade for Ligand Pharmaceuticals Incorporated was on March 4, 2025.
The single biggest insider buy for Ligand Pharmaceuticals Incorporated was from Bvf Partners L P/Il with a total value of $898,794.00 on Dec. 6, 2012.
The single biggest insider sell for Ligand Pharmaceuticals Incorporated was from Bvf Partners P/Il with a total value of $31,214,249.00 on Feb. 20, 2014.